Staff

Biora Therapeutics Announces Successful Completion of Second Device Performance Study in Human Subjects for its Targeted Therapeutics Platform

Study demonstrated device functioned as designed when administered with food, potentially enabling non-fasted administrationSAN DIEGO, July 07, 2022 (GLOBE NEWSWIRE)...

error: Content is protected !!